Market Highlights
Blepharitis is an ophthalmologic disorder which causes inflammation of the eyelids that leads to eye irritation. It is a common eye disorder that is caused by either bacteria or a skin condition like dandruff from the scalp or overproduction of oil from the glands of the eyelids.
Global Blepharitis Market is expected to grow a healthy growth at a CAGR of 6.5% during the forecast period.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5766
Segments
The global blepharitis market is segmented on the basis of type, treatment, diagnosis, and end user.
On the basis of type, the market is segmented into anterior blepharitis, posterior blepharitis, and mixed blepharitis.
On the basis of treatment, the market is segmented into eye cleansers, artificial tears, and antibiotic therapy. Antibiotic therapy segment is further sub-segmented into topical antibiotic therapy and oral antibiotic therapy.
On the basis of diagnosis, the market is segmented into the physical examination, comprehensive eye examination, and others.
On the basis of the end user, the market is segmented into specialty centers, hospitals, and others.
Regional Analysis
North America Blepharitis market is a growing market. On a regional basis, the Americas region is segmented into North America and South America. North America is segmented into the U.S. and Canada. Increasing incidence of eye disorders, along with rising awareness among population regarding eye care is likely to drive the market. Additionally, growing healthcare expenditure and rising involvement of leading players in new product development and rising government support is likely to enhance the growth of blepharitis market in North America. For instance, according to the Centers for Medicare & Medicaid Services, in 2015, the U.S. healthcare spending increased by 5.8% reaching USD 3.2 trillion.
Europe is the second largest market and holds a healthy share in the global blepharitis market. The European market is expected to grow at a healthy CAGR during the forecast period owing to the large pool of market players offering innovative products and rising skilled medical professionals along with growing demand for better and advanced healthcare infrastructure. For instance, according to the Organization for Economic Co-operation and Development (OECD), the healthcare expenditure in Germany was EUR 321 billion in 2014.This growing healthcare expenditure is driving the blepharitis market in Europe.
Asia Pacific is expected to be the fastest growing market. Increasing population eventually leading to rising patient population, rising prevalence of eye disorders are the major driver for the market growth. China is the fastest growing region owing to an increasingly older population. Rising awareness about the health and growing demand for healthcare facilities in emerging economies drive the market in this region. Rising healthcare expenditure and rise in awareness among the masses is driving the growth of blepharitis market in the Asia Pacific region.
The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness and limited treatment facilities. In the Middle East, United Arab Emirates is the largest market share owing to the development of healthcare industry and rising demand for advanced specialty centers.
Key Players
Some of the key players in the Blepharitis market are InSite Vision Incorporated, NovaBay Pharmaceuticals, Inc., Scope Ophthalmics Ltd, Thea Pharmaceuticals Limited, Perrigo Laboratories, Merck & Co., Galderma S.A., and Novartis AG.
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/blepharitis-market-5766
No comments:
Post a Comment